|
SGK196 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.082100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.374200E-01 |
| Normal-vs-Stage2 |
9.507700E-02 |
| Normal-vs-Stage3 |
7.420500E-04 |
| Normal-vs-Stage4 |
1.747190E-01 |
| Stage1-vs-Stage2 |
3.259000E-01 |
| Stage1-vs-Stage3 |
4.115900E-03 |
| Stage1-vs-Stage4 |
3.751600E-01 |
| Stage2-vs-Stage3 |
3.018400E-01 |
| Stage2-vs-Stage4 |
9.122000E-01 |
| Stage3-vs-Stage4 |
5.323400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.983500E-02 |
| Normal-vs-AfricanAmerican |
2.381500E-04 |
| Normal-vs-Asian |
2.362600E-01 |
| Caucasian-vs-AfricanAmerican |
9.319600E-03 |
| Caucasian-vs-Asian |
5.874500E-02 |
| AfricanAmerican-vs-Asian |
1.619290E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.701660E-02 |
| Normal-vs-Female |
2.171200E-01 |
| Male-vs-Female |
4.385200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.316800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.069600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.717600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.082740E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.482800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.684800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.352650E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.688000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.167750E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.215700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.659600E-01 |
| Normal-vs-Grade 2 |
1.491430E-01 |
| Normal-vs-Grade 3 |
9.609700E-02 |
| Normal-vs-Grade 4 |
9.429100E-04 |
| Grade 1-vs-Grade 2 |
3.271200E-01 |
| Grade 1-vs-Grade 3 |
1.632160E-01 |
| Grade 1-vs-Grade 4 |
2.689500E-02 |
| Grade 2-vs-Grade 3 |
6.657400E-01 |
| Grade 2-vs-Grade 4 |
2.977600E-02 |
| Grade 3-vs-Grade 4 |
7.781800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.084200E-01 |
| Normal-vs-ccB subtype |
2.334500E-02 |
| ccA subtype-vs-ccB subtype |
7.542400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.386990E-01 |
| Normal-vs-N1 |
5.864600E-01 |
| N0-vs-N1 |
9.908800E-01 |
|
|
